1. Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women 
George Christodoulakos, M.D., Irene Lambrinoudaki, M.D., Constantinos Panoulis, M.D., Constantinos Papadias, M.D., Emmanuel Economou, Ph.D., George Creatsas, M.D., F.A.C.S. 
Fertility and Sterility 
Volume 82, Issue 3, Pages (September 2004)
DOI: /j.fertnstert
Copyright © 2004 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Percentage changes from baseline (mean, SEM) in serum VE-cadherin in postmenopausal women receiving either 17β-E2 (2 mg)–norethisterone acetate (1 mg; E2-NETA) or raloxifene (60 mg). P values: comparison of baseline and 6-month values within the same treatment arm, Wilcoxon signed rank test.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2004 American Society for Reproductive Medicine Terms and Conditions